financetom
Business
financetom
/
Business
/
Denali Therapeutics ALS drug fails in mid-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Denali Therapeutics ALS drug fails in mid-stage trial
Jan 6, 2025 2:06 PM

Jan 6 (Reuters) - Denali Therapeutics ( DNLI ) said on

Monday its experimental drug failed to meet the main goal of a

mid-to-late stage trial in patients with amyotrophic lateral

sclerosis (ALS), a fatal neurodegenerative disease.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved